Preparation and in vitro characterisation of mucoadhesive polymeric microspheres as intra-nasal delivery systems

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 44, Issue 1, 1997, Pages 53-60

  Abd El Hameed, M D ^a   Kellaway, I W ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Microsphere preparation; Mucoadhesive polymers; Nasal delivery

Indexed keywords

CARBOMER; CHITOSAN; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; HYDROXYPROPYLMETHYLCELLULOSE; MICROSPHERE; POLYMER; SORBITAN ESTER; UNCLASSIFIED DRUG;

ADHESION; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; INTRANASAL DRUG ADMINISTRATION; MICROEMULSION; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY;

EID: 0345164320     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(97)00101-X     Document Type: Conference Paper

References (27)

1. L. Ilium, N. Farraj, H. Critchley, S.S. Davis, Nasal administration of gentamicin using a novel microsphere delivery system, Int. J. Pharm. 46 (1988) 261-265.
2. A.S. Harris, I.M. Nilsson, Z.G. Wagner, U. Alkner, Intranasal administration of peptides: nasal deposition biological response, and absorption of desmopressin, J. Pharm. Sci. 75 (1986) 1085-1088.
3. C. McMartin, L.E.F. Hutchinson, R. Hyde, G.E. Peters, Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity, J. Pharm. Sci. 76 (1987) 534-538.
4. K.S.E. Su, K.M. Companale, L.G. Mendelsohn, G.A. Kerchner, C.L. Gries, Nasal delivery of polypeptides I: Nasal absorption of enkephalins in rats, J. Pharm. Sci. 74 (1985) 394-398.
5. M.A. Hussain, A.B. Shinvi, S.M. Rowe, E. Shifter, The use of α-aminoboronic acid derivatives to stabilize peptide drugs during their intranasal absorption, Pharm. Res. 6 (1989) 186-189.
6. Y.W. Chien, S.F. Chang, Intranasal drug delivery for systemic medications, CRC Crit. Rev. Ther. Drug Carrier Syst. 4 (1987) 67-194.
7. A. Yammamoto, T. Morita, M. Hashida, H. Sezaki, Effect of absorption promoters on the nasal absorption of drugs with various molecular weights, Int. J. Pharm. 93 (1993) 91-99.
8. A.S. Harris, M. Ohlin, E. Svensson, S. Lethagen, I.M. Nilsson, Effect of the viscosity on the pharmacokinetics and biological response to intranasal desmopressin, J. Pharm. Sci. 78 (1989) 470-471.
9. T. Nagai, Y. Nishimoto, N. Nambu, Y. Suzuki, K. Sekine, Powder dosage form of insulin for nasal administration, J. Control. Release 1 (1984) 15-22.
10. E. Bjork, P. Edman, Degradable starch microspheres as a nasal delivery system for insulin, Int. J. Pharm. 47 (1988) 233-238.
11. P. Vidgren, M. Vidgren, J. Arppe, T. Hakuli, E. Laine, P. Paronen, In-vitro evauation of spray-dried mucoadhesive microspheres for nasal administration, Drug Dev. Ind. Pharm. 18 (1992) 581-597.
12. P. Edman, E. Bjork, L. Ryden, Microspheres as a nasal delivery system for peptide drugs, J. Control. Release 21 (1992) 165-172.
13. L. Illum, H. Jorgensen, H. Bisgaard, O. Krogsgaard, N. Rossing, Bioadhesive microspheres as a potintial nasal drug deliverey system, Int. J. Pharm. 39 (1987) 189-199.
14. T.-Y. Ting, I. Gonda, E.M. Gipps, Microparticles of polyvinyl alcohol for nasal delivery. I. Generation by spray-drying and spray-desolvation, Pharm. Res. 9 (1992) 1330-1335.
15. R.F. Hounam, A. Black, M. Walsh, The deposition of aerosol particles in the nasopharyngeal region of the human respiratory tract. Aerosol. Sci. 1971, pp. 2-47.
16. M. Murakami, Y. Kusanoi, K. Takada, S. Muranishi, Assessment of enhancing ability of medium-chain alkyl saccharides as new absorption enhancers in rat rectum, Int. J. Pharm. 79 (1992) 159-169.
17. A.J. Hoogstraate, C. Cullander, J.F. Nagelkerke, S. Senel, C. Verhoef, E. Junginger, E. Bodde, Diffusion rates and transport pathways of fluorescein isothiocyanate (FITC)-labeled model compounds through buccal epithelium, Pharm. Res. 11 (1994) 83-89.
18. L.M. Benedetti, E.M. Topp, V.J. Stella, Microspheres of hyaluronic acid esters-fabrication methods and in vitro hydrocortisone release, J. Control. Release 13 (1990) 33-41.
19. R. Mehvar, T.L. Shepard, Molecular-weight-dependent pharmacokinetics of fluorescein-labeled dextrans in rats, J. Pharm. Sci. 81 (1991) 908-912.
20. A.M. Durrani, S.J. Farr, I.W. Kellaway, Precorneal clearance of mucoadhesive microspheres from rabbit eye, J. Pharm. Pharmacol. 47 (1995) 581-584.
21. E.E.H. Hassan, R.C. Parish, J.M. Gallo, Optimized formulation of magnetic Chitosan microspheres containing the anticancer agent, oxantrazole, Pharm. Res. 9 (1992) 390-397.
22. E. Tomlinson, J.J. Burger, E.M.A. Schoonderwoerd, J. Kuik, F.C. Schlotz, J.G. McVie, S. Mill, Preparation and characterisation of albumin microspheres for intraarterial tumour targetting of cytotoxic compounds. J. Pharm. Pharmacol. 1982, p. 88.
23. S. Benita, A. Hoffman, M. Donbrow, Microcapsulation of paracetamol using polyacrylate resins (Eudragit Retard), kinetics of drug release and evaluation of kinetic model, J. Pharm. Pharmacol. 37 (1985) 391-395.
24. C.K. Kim, M.J. Kim, K.H. Oh, Preparation and evaluation of sustained release microspheres of terbutaline sulfate, Int. J. Pharm. 106 (1994) 213-219.
25. A. Barkai, Y.V. Pathak and S. Bentia, Polyacrylate (Eudragit Retard) microspheres for oral controlled release of nifedipine, formulation design and process optimization, Proceedings Eight Pharm. Tech. Conference, Mont-Carlo, March 29-31, 11, 1989, 1-21.
26. A. Amperiadou, M. Geogarakis, Controlled release salbutamol sulphate microcpsules prepared by emulsion solvent-evaporation technique and study on the release affected parameters, Int. J. Pharm. 115 (1995) 1-8.
27. L.-P. Morath, P. Edman, Dextran microspheres as a potential nasal drug delivery system for insulin - in vitro and in vivo properties, Int. J. Pharm. 124 (1995) 37-44.